Cargando…

Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy

BACKGROUND/AIMS: Patients with diabetes mellitus (DM) often suffer from gastrointestinal (GI) symptoms, but these correlate poorly to established objective GI motility measures. Our aim is to perform a detailed evaluation of potential measures of gastric and small intestinal motility in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinge, Mette W, Sutter, Nanna, Mark, Esben B, Haase, Anne-Mette, Borghammer, Per, Schlageter, Vincent, Lund, Sten, Fleischer, Jesper, Knudsen, Karoline, Drewes, Asbjørn M, Krogh, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Neurogastroenterology and Motility 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266501/
https://www.ncbi.nlm.nih.gov/pubmed/34210904
http://dx.doi.org/10.5056/jnm19195
_version_ 1783719960532484096
author Klinge, Mette W
Sutter, Nanna
Mark, Esben B
Haase, Anne-Mette
Borghammer, Per
Schlageter, Vincent
Lund, Sten
Fleischer, Jesper
Knudsen, Karoline
Drewes, Asbjørn M
Krogh, Klaus
author_facet Klinge, Mette W
Sutter, Nanna
Mark, Esben B
Haase, Anne-Mette
Borghammer, Per
Schlageter, Vincent
Lund, Sten
Fleischer, Jesper
Knudsen, Karoline
Drewes, Asbjørn M
Krogh, Klaus
author_sort Klinge, Mette W
collection PubMed
description BACKGROUND/AIMS: Patients with diabetes mellitus (DM) often suffer from gastrointestinal (GI) symptoms, but these correlate poorly to established objective GI motility measures. Our aim is to perform a detailed evaluation of potential measures of gastric and small intestinal motility in patients with DM type 1 and severe GI symptoms. METHODS: Twenty patients with DM and 20 healthy controls (HCs) were included. GI motility was examined with a 3-dimensional-Transit capsule, while organ volumes were determined by CT scans. RESULTS: Patients with DM and HCs did not differ with regard to median gastric contraction frequency (DM 3.0 contractions/minute [interquartile range {IQR}, 2.9-3.0]; HCs 2.9 [IQR, 2.8-3.1]; P = 0.725), amplitude of gastric contractions (DM 9 mm [IQR, 8-11]; HCs 11 mm (IQR, 9-12); P = 0.151) or fasting volume of the stomach wall (DM 149 cm3 [IQR, 112-187]; HCs 132 cm3 [IQR, 107-154]; P = 0.121). Median gastric emptying time was prolonged in patients (DM 3.3 hours [IQR, 2.6-4.6]; HCs 2.4 hours [IQR, 1.8-2.7]; P = 0.002). No difference was found in small intestinal transit time (DM 5 hours [IQR, 3.7-5.6]; HCs 4.8 hours [IQR, 3.9-6.0]; P = 0.883). However, patients with DM had significantly larger volume of the small intestinal wall (DM 623 cm3 [IQR, 487-766]; HCs 478 cm3 [IQR, 393-589]; P = 0.003). Among patients, 13 (68%) had small intestinal wall volume and 9 (50%) had gastric emptying time above the upper 95% percentile of HCs. CONCLUSION: In our study, gastric emptying time and volume of the small intestinal wall appeared to be the best objective measures in patients with DM type 1 and symptoms and gastroenteropathy.
format Online
Article
Text
id pubmed-8266501
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Neurogastroenterology and Motility
record_format MEDLINE/PubMed
spelling pubmed-82665012021-07-30 Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy Klinge, Mette W Sutter, Nanna Mark, Esben B Haase, Anne-Mette Borghammer, Per Schlageter, Vincent Lund, Sten Fleischer, Jesper Knudsen, Karoline Drewes, Asbjørn M Krogh, Klaus J Neurogastroenterol Motil Original Article BACKGROUND/AIMS: Patients with diabetes mellitus (DM) often suffer from gastrointestinal (GI) symptoms, but these correlate poorly to established objective GI motility measures. Our aim is to perform a detailed evaluation of potential measures of gastric and small intestinal motility in patients with DM type 1 and severe GI symptoms. METHODS: Twenty patients with DM and 20 healthy controls (HCs) were included. GI motility was examined with a 3-dimensional-Transit capsule, while organ volumes were determined by CT scans. RESULTS: Patients with DM and HCs did not differ with regard to median gastric contraction frequency (DM 3.0 contractions/minute [interquartile range {IQR}, 2.9-3.0]; HCs 2.9 [IQR, 2.8-3.1]; P = 0.725), amplitude of gastric contractions (DM 9 mm [IQR, 8-11]; HCs 11 mm (IQR, 9-12); P = 0.151) or fasting volume of the stomach wall (DM 149 cm3 [IQR, 112-187]; HCs 132 cm3 [IQR, 107-154]; P = 0.121). Median gastric emptying time was prolonged in patients (DM 3.3 hours [IQR, 2.6-4.6]; HCs 2.4 hours [IQR, 1.8-2.7]; P = 0.002). No difference was found in small intestinal transit time (DM 5 hours [IQR, 3.7-5.6]; HCs 4.8 hours [IQR, 3.9-6.0]; P = 0.883). However, patients with DM had significantly larger volume of the small intestinal wall (DM 623 cm3 [IQR, 487-766]; HCs 478 cm3 [IQR, 393-589]; P = 0.003). Among patients, 13 (68%) had small intestinal wall volume and 9 (50%) had gastric emptying time above the upper 95% percentile of HCs. CONCLUSION: In our study, gastric emptying time and volume of the small intestinal wall appeared to be the best objective measures in patients with DM type 1 and symptoms and gastroenteropathy. The Korean Society of Neurogastroenterology and Motility 2021-07-30 2021-07-30 /pmc/articles/PMC8266501/ /pubmed/34210904 http://dx.doi.org/10.5056/jnm19195 Text en © 2021 The Korean Society of Neurogastroenterology and Motility https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Klinge, Mette W
Sutter, Nanna
Mark, Esben B
Haase, Anne-Mette
Borghammer, Per
Schlageter, Vincent
Lund, Sten
Fleischer, Jesper
Knudsen, Karoline
Drewes, Asbjørn M
Krogh, Klaus
Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title_full Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title_fullStr Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title_full_unstemmed Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title_short Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy
title_sort gastric emptying time and volume of the small intestine as objective markers in patients with symptoms of diabetic enteropathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266501/
https://www.ncbi.nlm.nih.gov/pubmed/34210904
http://dx.doi.org/10.5056/jnm19195
work_keys_str_mv AT klingemettew gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT sutternanna gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT markesbenb gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT haaseannemette gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT borghammerper gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT schlagetervincent gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT lundsten gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT fleischerjesper gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT knudsenkaroline gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT drewesasbjørnm gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy
AT kroghklaus gastricemptyingtimeandvolumeofthesmallintestineasobjectivemarkersinpatientswithsymptomsofdiabeticenteropathy